Letter to the Editor: Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Steatohepatitis Cirrhosis and Diabetes: Insufficient for Individual Management
Zhichao Feng, Pengfei Rong, Wei Wang – 6 January 2020
Zhichao Feng, Pengfei Rong, Wei Wang – 6 January 2020
Zhibin Liao, Lin Chen, Xuewu Zhang, Hongwei Zhang, Xiaolong Tan, Keshuai Dong, Xun Lu, He Zhu, Qiumeng Liu, Zhanguo Zhang, Zeyang Ding, Wei Dong, Peng Zhu, Liang Chu, Huifang Liang, Pran K. Datta, Bixiang Zhang, Xiaoping Chen – 6 January 2020
6 January 2020
Moira B. Hilscher, Vijay H. Shah – 5 January 2020
Alberto Ferrarese, Maria Cristina Morelli, Paola Carrai, Martina Milana, Mario Angelico, Giovanni Perricone, Luca Saverio Belli, Giuseppe Marrone, Antonio Grieco, Silvia Martini, Matteo Angelo Manini, Stefano Fagiuoli, Pierluigi Toniutto, Alfonso Galeota Lanza, Sherrie Bhoori, Salvatore Petta, Edoardo G. Giannini, Patrizia Burra – 4 January 2020 – Wilson’s disease (WD) is a rare genetic disorder with protean manifestations.
Wentao Wang, Chun Yang, Kai Zhu, Li Yang, Ying Ding, Rongkui Luo, Shuo Zhu, Caizhong Chen, Wei Sun, Mengsu Zeng, Sheng‐Xiang Rao – 4 January 2020 – Small recurrent hepatocellular carcinoma (HCC) can show atypical imaging patterns, and a specific diagnostic algorithm for HCC is lacking. This study aimed to better characterize postoperative recurrent HCCs <20 mm in size with gadoxetic acid–enhanced magnetic resonance imaging (MRI). We evaluated 373 newly developed nodules after hepatectomy in 204 HCC patients with chronic hepatitis B virus infection.
Stefan Stender, Vlad G. Zaha, Craig R. Malloy, Jessica Sudderth, Ralph J. DeBerardinis, Jae Mo Park – 4 January 2020 – Carbon‐13 magnetic resonance spectroscopy (MRS) following oral intake of 13C‐labeled glucose is the gold standard for imaging glycogen metabolism in humans. However, the temporal resolution of previous studies has been >13 minutes. Here, we describe a high‐sensitivity 13C MRS method for imaging hepatic glycogen synthesis with a temporal resolution of 1 minute or less.
Ju Dong Yang, Kristin C. Mara, Gregory J. Gores, Lewis R. Roberts – 4 January 2020
Ju Dong Yang, Kristin C. Mara, Gregory J. Gores, Lewis R. Roberts – 4 January 2020
Joan Ericka Flores, Shivakumar Chitturi, Sarah Walker – 3 January 2020 – Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.